[PDF][PDF] Pan-cancer proteogenomics connects oncogenic drivers to functional states
Cancer driver events refer to key genetic aberrations that drive oncogenesis; however, their
exact molecular mechanisms remain insufficiently understood. Here, our multi-omics pan …
exact molecular mechanisms remain insufficiently understood. Here, our multi-omics pan …
[PDF][PDF] Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Post-translational modifications (PTMs) play key roles in regulating cell signaling and
physiology in both normal and cancer cells. Advances in mass spectrometry enable high …
physiology in both normal and cancer cells. Advances in mass spectrometry enable high …
[PDF][PDF] Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
DNA methylation plays a critical role in establishing and maintaining cellular identity.
However, it is frequently dysregulated during tumor development and is closely intertwined …
However, it is frequently dysregulated during tumor development and is closely intertwined …
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
M Takahashi, HB Chong, S Zhang, TY Yang… - Cell, 2024 - cell.com
Cysteine-focused chemical proteomic platforms have accelerated the clinical development
of covalent inhibitors for a wide range of targets in cancer. However, how different oncogenic …
of covalent inhibitors for a wide range of targets in cancer. However, how different oncogenic …
[HTML][HTML] Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine
A Jose, P Kulkarni, J Thilakan, M Munisamy… - Molecular Cancer, 2024 - Springer
Despite advancements in treatment protocols, cancer is one of the leading cause of deaths
worldwide. Therefore, there is a need to identify newer and personalized therapeutic targets …
worldwide. Therefore, there is a need to identify newer and personalized therapeutic targets …
[HTML][HTML] TMO-Net: an explainable pretrained multi-omics model for multi-task learning in oncology
F Wang, Z Zhuang, F Gao, R He… - Genome …, 2024 - genomebiology.biomedcentral.com
Cancer is a complex disease composing systemic alterations in multiple scales. In this study,
we develop the Tumor Multi-Omics pre-trained Network (TMO-Net) that integrates multi …
we develop the Tumor Multi-Omics pre-trained Network (TMO-Net) that integrates multi …
A proteogenomics data-driven knowledge base of human cancer
By combining mass-spectrometry-based proteomics and phosphoproteomics with genomics,
epi-genomics, and transcriptomics, proteogenomics provides comprehensive molecular …
epi-genomics, and transcriptomics, proteogenomics provides comprehensive molecular …
Proteomic insights into paediatric cancer: Unravelling molecular signatures and therapeutic opportunities
Survival rates in some paediatric cancers have improved greatly over recent decades, in
part due to the identification of diagnostic, prognostic and predictive molecular signatures …
part due to the identification of diagnostic, prognostic and predictive molecular signatures …
[HTML][HTML] Frequent loss of FAM126A expression in colorectal cancer results in selective FAM126B dependency
S Li, T Han - Iscience, 2024 - cell.com
Most advanced colorectal cancer (CRC) patients cannot benefit from targeted therapy due to
lack of actionable targets. By mining data from the DepMap, we identified FAM126B as a …
lack of actionable targets. By mining data from the DepMap, we identified FAM126B as a …
ClinicalOmicsDB: exploring molecular associations of oncology drug responses in clinical trials
Matching patients to optimal treatment is challenging, in part due to the limited availability of
real-world clinical datasets for predictive biomarker identification. The growing integration of …
real-world clinical datasets for predictive biomarker identification. The growing integration of …